Multicenter study shows which treatment helps most with high-risk acute pulmonary embolism by University Hospital of Bonn Editors' notes The GIST Add as preferred source ...

Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study. TACE with or without ...

This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.

Prospective multicenter clinical study will evaluate outcomes associated with posterior sacroiliac joint procedures utilizing the cortical-piercing TRAQ™ allograft. TAMPA, Fla., ...